EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access

Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30

Macarena I de la Fuente iD, Priscilla K Brastianos, Bradley Gampel, Farshad Nassiri, David R Raleigh iD, Cristiane M Ida, Mohamed S Abdelbaki, Melike Pekmezci, Stephen Bagley, Jacob S Young, Rimas V Lukas iD, Angela C Hirbe und 8 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf255 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Macarena I de la Fuente und 19 weiteren Autor:innen. Beteiligte Einrichtung: Sylvester Comprehensive Cancer Center, University of Miami, Miami (M.I.D., B.G.). Hauptthemen laut MEDLINE: Societies, Medical, Medical Oncology, Brain Neoplasms, Neurology. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Dowskin Family Foundation, and by National Institutes of Health, The Sylvester Comprehensive Cancer Center, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Society for Neuro-Oncology (SNO) marks its 30th anniversary in 2025, providing an opportunity to reflect on scientific advances and future directions on the field. Over three decades, SNO has catalyzed scientific innovation, education, mentorship, and global collaboration, advancing the care of patients with primary and metastatic brain tumors. Through its annual meeting and subspecialty conferences in pediatric neuro-oncology and brain metastases, as well as its journals, including Neuro-Oncology, Neuro-Oncology Practice, Neuro-Oncology Advances, and the recently launched Neuro-Oncology Pediatrics, SNO has established leading platforms for disseminating knowledge, sharing best practices, and shaping clinical, translational, and basic research worldwide. Scientific milestones during this period include the integration of molecular profiling into CNS tumor classification, advances in neuroimaging for diagnosis and treatment monitoring, targeted therapies for selected glioma patients and the evolution of brain metastases management from whole-brain radiotherapy to multimodal strategies that incorporate targeted and immune-based therapies. Pediatric neuro-oncology has similarly advanced with the use of histomolecular diagnostics, refined risk stratification, and the development of novel targeted agents, alongside an increased emphasis on survivorship. Looking forward, emerging insights into the tumor microenvironment and novel immunotherapeutic approaches offer promising directions for future discovery and translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Societies, MedicalMedical OncologyBrain NeoplasmsNeurologyHumansHistory, 21st CenturyHistory, 20th Century

Stichwörter der Autor:innen

Society for Neuro-Oncology (SNO)brain metastasesgliomapediatric neuro-oncology

Autor:innen und Institutionen

  • Sylvester Comprehensive Cancer Center, University of Miami, Miami (M.I.D., B.G.).
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston.
  • Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco (S.M.C.).

ORCID-Profile: Macarena I de la Fuente, David R Raleigh, Rimas V Lukas, Javier Villanueva-Meyer, Anna Lasorella, Jann N Sarkaria, David H Gutmann, Daphne Haas-Kogan, Evanthia Galanis, Susan M Chang

Förderung

  • The Dowskin Family Foundation, and by National Institutes of Health
  • The Sylvester Comprehensive Cancer Center
  • NCI NIH HHS

Zitieren

APA

de la Fuente, M. I., Brastianos, P. K., Gampel, B., Nassiri, F., Raleigh, D. R., Ida, C. M., Abdelbaki, M. S., Pekmezci, M., Bagley, S., Young, J. S., Lukas, R. V., Hirbe, A. C., Ellingson, B. M., Villanueva-Meyer, J., Lasorella, A., Sarkaria, J. N., Gutmann, D. H., Haas-Kogan, D., Galanis, E., & Chang, S. M. (2025). Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf255

Vancouver

de la Fuente MI, Brastianos PK, Gampel B, Nassiri F, Raleigh DR, Ida CM, et al. Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf255

BibTeX
@article{delaFuente2025,
  author = {de la Fuente, Macarena I and Brastianos, Priscilla K and Gampel, Bradley and Nassiri, Farshad and Raleigh, David R and Ida, Cristiane M and Abdelbaki, Mohamed S and Pekmezci, Melike and Bagley, Stephen and Young, Jacob S and Lukas, Rimas V and Hirbe, Angela C and Ellingson, Benjamin M and Villanueva-Meyer, Javier and Lasorella, Anna and Sarkaria, Jann N and Gutmann, David H and Haas-Kogan, Daphne and Galanis, Evanthia and Chang, Susan M},
  title = {Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf255}
}
Kostenlos starten →